World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
37254
World Ranking
12507
National Ranking
389

Overview

Denis Caillot is affiliated with Grenoble Alpes University in France and has an extensive publication record primarily in the fields of medicine, biochemistry, genetics, and molecular biology. Their research focuses on hematology, molecular biology, and oncology, with additional work in genetics and pathology and forensic medicine.

The scientist's main research topics include multiple myeloma research and treatments, protein degradation and inhibitors, peptidase inhibition and analysis, CAR-T cell therapy research, acute myeloid leukemia research, chronic lymphocytic leukemia research, and cancer treatment and pharmacology.

Recent significant papers authored by or associated with Caillot include:

  • Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial (2021, The Lancet Oncology)
  • Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial (2022, Clinical Infectious Diseases)
  • Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma (2020, Journal of Clinical Oncology)
  • Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial (2020, Blood)
  • Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA (2022, Leukemia)

Frequent co-authors collaborating with Caillot include:

  • Philippe Moreau
  • Aurore Perrot
  • Xavier Leleu
  • Cyrille Hulin
  • Hervé Avet-Loiseau

The scientist publishes regularly in leading journals related to hematology and oncology. Prominent venues where Caillot has multiple publications include:

  • Blood
  • Journal of Clinical Oncology
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia
  • Bone Marrow Transplantation

Best Publications

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett

  • Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

    Michel Attal;Jean-Luc Harousseau;Thierry Facon;François Guilhot

  • Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

    Michel Attal;Valerie Lauwers-Cances;Gerald Marit;Denis Caillot

  • Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

    Michel Attal;Valerie Lauwers-Cances;Cyrille Hulin;Xavier Leleu

  • Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

    Hervé Avet-Loiseau;Michel Attal;Philippe Moreau;Catherine Charbonnel

  • Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

    David W. Denning;Patricia Ribaud;Noel Milpied;Denis Caillot

  • Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.

    Denis Caillot;Olivier Casasnovas;Alain Bernard;Jean-Francois Couaillier

  • Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

    Philippe Moreau;Michel Attal;Cyrille Hulin;Bertrand Arnulf

  • Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

    Michel Attal;Jean-Luc Harousseau;Serge Leyvraz;Chantal Doyen

  • Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With Neutropenia

    Denis Caillot;Jean-Francois Couaillier;Alain Bernard;Olivier Casasnovas

  • Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial

    Philippe Moreau;Thierry Facon;Michel Attal;Cyrille Hulin

  • Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.

    Jean-Luc Harousseau;Michel Attal;Hervé Avet-Loiseau;Gerald Marit

  • Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    Michel Attal;Paul G. Richardson;S. Vincent Rajkumar;Jesus San-Miguel

  • Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.

    Philip L. McCarthy;Sarah A. Holstein;Maria Teresa Petrucci;Paul G. Richardson

  • Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

    Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave

  • Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p)

    Hervé Avet-Loiseau;Xavier Leleu;Murielle Roussel;Philippe Moreau

  • Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma.

    Frederic Garban;Michel Attal;Mauricette Michallet;Cyrille Hulin

  • Comparison of Autologous Bone Marrow Transplantation and Intensive Chemotherapy as Postremission Therapy in Adult Acute Myeloid Leukemia

    Jean-Luc Harousseau;Jean-Yves Cahn;Bernard Pignon;Francis Witz

  • Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia

    S. De Botton;H. Dombret;M. Sanz;J. San Miguel

  • Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. Commentary

    Giampaolo Merlini;Michel Attal;Jean-Luc Harousseau;Serge Leyvraz

Frequent Co-Authors

Michel Attal
Michel Attal Janssen (Belgium)
Thierry Facon
Thierry Facon Centre Hospitalier Régional et Universitaire de Lille
Philippe Moreau
Philippe Moreau University of Nantes
Xavier Leleu
Xavier Leleu Harvard University
Jean-Luc Harousseau
Jean-Luc Harousseau University of Nantes
Eric Solary
Eric Solary Institut Gustave Roussy
Mauricette Michallet
Mauricette Michallet University of Helsinki
Emmanuel Raffoux
Emmanuel Raffoux Hôpital Saint-Louis
Hervé Dombret
Hervé Dombret Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t always mean becoming a physician. Many students choose alternative healthcare degrees online, offering diverse roles, flexibility, and career advancement. Allied health fields, healthcare administration, and advanced nursing are all popular pathways for those wanting to impact patient care or health systems.

For those interested in mental health, online pmhnp programs enable registered nurses to specialize as psychiatric-mental health nurse practitioners, often in less time. If you see yourself managing clinics or hospital operations, a bachelors in healthcare administration provides a solid foundation for leadership roles in healthcare settings.

Aspiring executives may benefit from affordable online mha programs that lead to high-level healthcare management positions. Nursing professionals interested in the highest clinical degrees without breaking the bank should explore cheapest dnp online programs.

These accredited online degrees offer flexible schedules and open new doors for advancement and specialization in the dynamic U.S. healthcare landscape.

Best Scientists Citing Denis Caillot

Trending Scientists